Given this unifying pathophysiology, GLP-1 RAs, with their powerful ability to act both centrally (controlling appetite and cravings) and peripherally (correcting systemic metabolic dysfunction, resolving hepatic steatosis and inflammation), to exert direct anti-carcinogenic effects, represent a truly multi-functional therapeutic tool
+ We do not treat patients who are pregnant or breastfeeding, who have a known allergy to any component of the formulation including pineapple-derived bromelain, who have an active skin infection in the treatment area, who have a bleeding disorder or are on certain blood-thinning medications, who have significant liver, kidney or heart disease, or who have a history of keloid scarring
Retrieved from NovoCare-b
Injections are good at treating more severe deficiencies, says Foxx